Microalgae as Antimicrobial and Antibiofilm Agents: A Review
Science Letters · 30.01.2025 · 19 (1) · 60-74
DOI: 10.24191/scl.v19i1.6351 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Letters, online erschienen am 30.01.2025. Verfasst von Syaza Syasya Lakman und 2 weiteren Autor:innen. Die Arbeit wurde bisher 4-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-SA 4.0).
Abstract (Originalsprache)
Bacterial biofilms produce the majority of medical infections, and biofilm formation is also associated with 60–70% of nosocomial infections. It has become a huge public health concern as antibiotics' effectiveness is dwindling at an alarming rate due to the emergence of antibiotic-resistant microbes. Microalgae, both eukaryotic and prokaryotic, have been found to produce intracellular and extracellular metabolites with a variety of biological activities, such as antibacterial, antifungal, antiviral, and antibiofilm activity by microalgae and cyanobacteria species. Several compounds have been reported to possess antimicrobial and antibiofilm activity, including phenol, hexadecanoic acid, phycocyanin, phycobiliproteins, hassallidin, parsinguine, gambierdic acids, tannins, terpenoids, and flavonoids. This review outlines the uses of microalgae as a renewable and underexploited resource for antimicrobial and antibiofilm agents and their prospects.
Zitieren
APA
Lakman, S. S., Zakaria, N. A., & Jalil, M. T. M. (2025). Microalgae as Antimicrobial and Antibiofilm Agents: A Review. Science Letters, 19(1), 60-74. https://doi.org/10.24191/scl.v19i1.6351
Vancouver
Lakman SS, Zakaria NA, Jalil MTM. Microalgae as Antimicrobial and Antibiofilm Agents: A Review. Science Letters. 2025;19(1):60-74. doi:10.24191/scl.v19i1.6351
BibTeX
@article{Lakman2025,
author = {Lakman, Syaza Syasya and Zakaria, Nurul Aili and Jalil, Mohd Taufiq Mat},
title = {Microalgae as Antimicrobial and Antibiofilm Agents: A Review},
journal = {Science Letters},
year = {2025},
volume = {19},
number = {1},
pages = {60--74},
doi = {10.24191/scl.v19i1.6351}
}
EUVIMED